# Amundi MSCI India Swap UCITS ETF Act -USD Acc- (INRL) **Page:** https://fundology.uk/fund/inrl · ISIN FR0010375766 ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 13/11/2026, INRL (Amundi MSCI India Swap UCITS ETF Act -USD Acc-, ISIN FR0010375766) closed at £23.03 on the London Stock Exchange. Its ongoing charge is 0.85% a year (about £85 on £10,000). Over the five years to 13/11/2026 its total return was +11.4%, or −13.0% after UK CPIH inflation. ## Summary Amundi MSCI India Swap UCITS ETF Act -USD Acc- is an exchange-traded fund (ETF) from Amundi, launched in 2006. It tracks the MSCI India. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.85% a year — about £85 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£23.03** (13/11/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | INRL | | ISIN | FR0010375766 | | Also listed as | INRU (London Stock Exchange, US dollars) | | Category | Emerging markets | | Type | ETF | | Provider | Amundi | | Tracks | MSCI India | | Income | Accumulating | | Ongoing charge | 0.85% a year (£85 per £10,000) | | Fund size | £128m | | Launched | 2006 | | Domicile | France | | UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 09/05/2019 | ## Past returns (periods to 13/11/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | -7.13% | -10.42% | income reinvested | | 3 years | +10.67% | -0.01% | income reinvested | | 5 years | +11.41% | -13.04% | income reinvested | Returns: as reported (delayed data). Inflation: UK CPIH, latest month published. ## Calendar-year returns Calendar-year returns of Amundi MSCI India Swap UCITS ETF Act -USD Acc- in pounds (price, with income reinvested in the fund): 2022 +1.5%, 2023 +12.6%, 2024 +13.9%, 2025 −7.2%; 2026 to 13/11/2026 −5.5%. Returns of Amundi MSCI India Swap UCITS ETF Act -USD Acc- in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: −12.0%; to 30/09/2025: −15.2%; to 30/09/2024: +28.1%; to 30/09/2023: −0.6%; to 30/09/2022: +7.5%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2022 | +1.5% | -7.1% | Price | | 2023 | +12.6% | +8.1% | Price | | 2024 | +13.9% | +10.0% | Price | | 2025 | -7.2% | -10.4% | Price | | 2026 to 13/11/2026 | -5.5% | -8.5% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 18.95% | -18.74% | | 3 years | 16.08% | -26.36% | | 5 years | 15.88% | -26.36% | ## Largest fall Volatility of Amundi MSCI India Swap UCITS ETF Act -USD Acc- in pounds, annualised from weekly returns to 13/11/2026: 18.9% over 1 year, 16.1% over 3 years, 15.9% over 5 years. Largest fall in the price of Amundi MSCI India Swap UCITS ETF Act -USD Acc- since November 2021, in pounds: −26.4% from 27/09/2024 to 27/03/2026. The lowest 12-month return of Amundi MSCI India Swap UCITS ETF Act -USD Acc- in pounds (price, with income reinvested in the fund) since January 2021 was −17.9% (12 months to 23/10/2026); the highest was +34.5% (12 months to 12/07/2024). On 13/11/2026 the price of Amundi MSCI India Swap UCITS ETF Act -USD Acc- was 16.5% below its highest weekly close since November 2021 (27/09/2024), in pounds. ## Charges compared with similar funds Ongoing charge of Amundi MSCI India Swap UCITS ETF Act -USD Acc- 0.85% a year. Compared on 14/11/2026, 2 of the 151 other emerging-market share funds charge more, 2 the same and 147 less (share classes counted once). ## Funds tracking the same index 5 funds track MSCI India, this one included and share classes counted once; their ongoing charges range from 0.15% to 0.85% a year (13/11/2026). | Fund | Ongoing charge | 1 year | 3 years | 5 years | |---|---|---|---|---| | Amundi Index Solutions - Amundi MSCI India Swap II UCITS ETF USD Acc | 0.80% | -6.1% | +9.1% | +11.6% | | Amundi MSCI India Swap UCITS ETF Act -USD Acc- (this fund) | 0.85% | -7.1% | +10.7% | +11.4% | | iShares MSCI India UCITS ETF | 0.65% | -6.6% | +11.6% | +15.4% | | UBS (Irl) Fund Solutions PLC - UBS MSCI INDIA SF UCITS ETF Accum USD | 0.15% | -3.8% | — | — | | Xtrackers MSCI INDIA SWAP UCITS ETF Capitalisation 1C | 0.19% | -6.3% | +10.1% | +12.6% | Returns are as reported, in pounds, income reinvested unless marked "(price)". ## Charges & eligibility - Ongoing charges figure (OCF): **0.85%** per year (as of 13/11/2026) - Stocks and shares ISA eligible: usually (check with your platform) - SIPP eligible: usually (check with your provider) - ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify. ## What it holds INRL is a swap-based (synthetic) fund: it gets the return of the index it tracks through a swap. Its published holdings, as of 11/11/2026, are the substitute basket of securities the fund holds as collateral, not the companies in that index. ### Top holdings Largest positions (as of 11/11/2026), as a percentage of the whole fund: | # | Holding | Ticker | Weight | |---|---|---|---| | 1 | UnitedHealth Group | [UNH](https://fundology.uk/stock/UNH) | 8.33% | | 2 | Amazon | [AMZN](https://fundology.uk/stock/AMZN) | 7.96% | | 3 | Morgan Stanley | [MS](https://fundology.uk/stock/MS) | 6.63% | | 4 | Costco Wholesale | [COST](https://fundology.uk/stock/COST) | 6.60% | | 5 | CVS Health | [CVS](https://fundology.uk/stock/CVS) | 4.66% | | 6 | Lam Research | [LRCX](https://fundology.uk/stock/LRCX) | 4.34% | | 7 | Procter & Gamble | [PG](https://fundology.uk/stock/PG) | 4.27% | | 8 | AbbVie | [ABBV](https://fundology.uk/stock/ABBV) | 4.04% | | 9 | Broadcom | [AVGO](https://fundology.uk/stock/AVGO) | 3.90% | | 10 | Cigna Group | [CI](https://fundology.uk/stock/CI) | 3.89% | The 49 holdings on record (of 65 reported): https://fundology.uk/fund/inrl/holdings ## Questions people ask **What is the ongoing charge of INRL?** The ongoing charge of INRL is 0.85% a year — about £85 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Amundi MSCI India Swap UCITS ETF Act -USD Acc- 0.85% a year. Compared on 14/11/2026, 2 of the 151 other emerging-market share funds charge more, 2 the same and 147 less (share classes counted once). **What does INRL track?** INRL tracks the MSCI India. **Is INRL accumulating or distributing?** INRL is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of INRL?** The ISIN of INRL is FR0010375766. An ISIN identifies one exact share class of a fund; INRL is its ticker on the London Stock Exchange. The same share class is also listed as INRU (London Stock Exchange, US dollars). **What does INRL hold?** INRL is a swap-based (synthetic) fund: it gets the return of the index it tracks through a swap. Its published holdings, as of 11/11/2026, are the substitute basket of securities the fund holds as collateral, not the companies in that index. **What were INRL’s returns in each of the last five years?** Calendar-year returns of INRL in pounds (price, with income reinvested in the fund): 2022 +1.5%, 2023 +12.6%, 2024 +13.9%, 2025 −7.2%; 2026 to 13/11/2026 −5.5%. Past performance is not a guide to future returns. **How has INRL done after inflation?** Over the five years to 13/11/2026 INRL’s total return was +11.4%, or −13.0% after UK CPIH inflation. Past performance is not a guide to future returns. ## Fund documents - [Fund page at Amundi](https://www.amundietf.co.uk/en/professional/products/equity/amundi-msci-india-swap-ucits-etf-usd-acc/fr0010375766) - Links checked 12/10/2026. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.